Zero % Pacemaker Infection Rate Achieved in a Non-Operating Room Setting

Abstract

Background: Excessive use of Vancomycin especially in the treatment of Clostridium difficile and methicillinresistant Staphylococcus aureus (MRSA) infections as well as the preferential use of Vancomycin in the treatment of catheter-related infections in hemodialysis patients has long been suspected as the culprit in exerting selective pressure and inducing resistance among enterococcal species. The aim of the study was to determine whether measures to reduce Vancomycin usage would result in the reduction of VRE among enterococci.